Narrative review / 2024
A Delphi expert consensus emphasized clinical symptoms for diagnosing vitamin B12 deficiency and parenteral treatment for acute, severe manifestations.
Researchers conducted a scoping review of PubMed literature since January 2003 to inform a two-round Delphi survey among 42 experts regarding vitamin B12 deficiency. Panelists agreed that recognition of clinical symptoms should receive the highest priority for diagnosis, supported by serum B12 screening and methylmalonic acid or homocysteine testing. Parenteral B12 was viewed as the initial first choice for acute and severe manifestations, while high-dose oral B12 may be considered for long-term treatment. Prophylactic B12 supplementation was also supported for specific high-risk groups.
- Study type
- Two-round Delphi expert consensus study
- Who was studied
- 42 experts participating in a two-round Delphi survey
- What was measured
- Expert consensus on diagnosis, treatment, and long-term management of vitamin B12 deficiency
THE PAPER
Diagnosis, Treatment and Long-Term Management of Vitamin B12 Deficiency in Adults: A Delphi Expert Consensus.
Obeid R, Andrès E, Češka R, Hooshmand B, Guéant-Rodriguez RM, Prada GI, Sławek J, Traykov L, Ta Van B, Várkonyi T, Reiners K, The Vitamin B Consensus Panelists Group . J Clin Med, 2024.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.